On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...